PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TRIPLE-NEGATIVE BREAST CANCER
The present invention relates to a compound represented by chemical formula 1 in the present specification, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising a chemotherapeutic agent, wherein the pharmaceutical composition can be effectively used in the preve...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French Korean |
Published |
06.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a compound represented by chemical formula 1 in the present specification, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising a chemotherapeutic agent, wherein the pharmaceutical composition can be effectively used in the prevention or treatment of triple-negative breast cancer.
La présente invention concerne un composé représenté par la formule chimique 1 dans la présente description, ou un sel pharmaceutiquement acceptable de celui-ci, et une composition pharmaceutique comprenant un agent chimiothérapeutique, la composition pharmaceutique pouvant être efficacement utilisée dans la prévention ou le traitement du cancer du sein triple négatif.
본 발명은 본 명세서의 화학식 1로 표기되는 화합물, 또는 이의 약학적으로 허용가능한 염, 및 화학요법제를 포함하는 약학적 조성물을 제공하는 것으로, 상기 약학적 조성물은 삼중음성유방암의 예방 또는 치료에 유용하게 사용할 수 있다. |
---|---|
Bibliography: | Application Number: WO2022KR21693 |